Cargando…
Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review
INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome refers to a cluster of clinical symptoms/signs related to drug hypersensitivity. The main clinical features include fever, skin rash, eosinophilia, enlarged lymph nodes, atypical lymphocytosis, and involvement of at...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567655/ http://dx.doi.org/10.1192/j.eurpsy.2022.1854 |
_version_ | 1784809454465712128 |
---|---|
author | De Filippis, R. De Fazio, P. Kane, J. Schoretsanitis, G. |
author_facet | De Filippis, R. De Fazio, P. Kane, J. Schoretsanitis, G. |
author_sort | De Filippis, R. |
collection | PubMed |
description | INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome refers to a cluster of clinical symptoms/signs related to drug hypersensitivity. The main clinical features include fever, skin rash, eosinophilia, enlarged lymph nodes, atypical lymphocytosis, and involvement of at least one internal organ. Clozapine-related DRESS syndrome has been rarely reported, but this may be due to a different clinical presentation pattern compared to DRESS for other culprit drugs. OBJECTIVES: We aimed to assess clusters of main clinical features of clozapine-related DRESS. METHODS: We ran a network analysis for clinical manifestations in the pooled sample of all previous published cases of clozapine-related DRESS. RESULTS: We observed a triad of core symptoms (i.e., organ implication, fever, and eosinophilia) among DRESS criteria co-occurring in 59.3% (n=16) of 27 patients. The organs most likely to be involved in clozapine-related DRESS included lungs, liver, heart, and kidneys. Fever was also present in almost all cases (n=25 patients), while eosinophilia was observed in two thirds of the sample (n=18 patients). CONCLUSIONS: Regarding clinical manifestations clozapine-related DRESS may differ from DRESS for other culprit drugs as skin reaction is not very typical; thus, clinicians need to consider DRESS as a potential diagnosis even in absence of a skin reaction. When managing clozapine-treated patients with the core triad of organ implication, fever, and eosinophilia clinicians should consider guidelines for DRESS treatment. DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9567655 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-95676552022-10-17 Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review De Filippis, R. De Fazio, P. Kane, J. Schoretsanitis, G. Eur Psychiatry Abstract INTRODUCTION: Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome refers to a cluster of clinical symptoms/signs related to drug hypersensitivity. The main clinical features include fever, skin rash, eosinophilia, enlarged lymph nodes, atypical lymphocytosis, and involvement of at least one internal organ. Clozapine-related DRESS syndrome has been rarely reported, but this may be due to a different clinical presentation pattern compared to DRESS for other culprit drugs. OBJECTIVES: We aimed to assess clusters of main clinical features of clozapine-related DRESS. METHODS: We ran a network analysis for clinical manifestations in the pooled sample of all previous published cases of clozapine-related DRESS. RESULTS: We observed a triad of core symptoms (i.e., organ implication, fever, and eosinophilia) among DRESS criteria co-occurring in 59.3% (n=16) of 27 patients. The organs most likely to be involved in clozapine-related DRESS included lungs, liver, heart, and kidneys. Fever was also present in almost all cases (n=25 patients), while eosinophilia was observed in two thirds of the sample (n=18 patients). CONCLUSIONS: Regarding clinical manifestations clozapine-related DRESS may differ from DRESS for other culprit drugs as skin reaction is not very typical; thus, clinicians need to consider DRESS as a potential diagnosis even in absence of a skin reaction. When managing clozapine-treated patients with the core triad of organ implication, fever, and eosinophilia clinicians should consider guidelines for DRESS treatment. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9567655/ http://dx.doi.org/10.1192/j.eurpsy.2022.1854 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract De Filippis, R. De Fazio, P. Kane, J. Schoretsanitis, G. Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review |
title | Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review |
title_full | Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review |
title_fullStr | Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review |
title_full_unstemmed | Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review |
title_short | Co-occurrence of clozapine-related DRESS syndrome core clinical manifestations: results of a systematic review |
title_sort | co-occurrence of clozapine-related dress syndrome core clinical manifestations: results of a systematic review |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9567655/ http://dx.doi.org/10.1192/j.eurpsy.2022.1854 |
work_keys_str_mv | AT defilippisr cooccurrenceofclozapinerelateddresssyndromecoreclinicalmanifestationsresultsofasystematicreview AT defaziop cooccurrenceofclozapinerelateddresssyndromecoreclinicalmanifestationsresultsofasystematicreview AT kanej cooccurrenceofclozapinerelateddresssyndromecoreclinicalmanifestationsresultsofasystematicreview AT schoretsanitisg cooccurrenceofclozapinerelateddresssyndromecoreclinicalmanifestationsresultsofasystematicreview |